Cleared Traditional

K133697 - BREAST-MED TISSUE MARKER

K133697 is an FDA 510(k) clearance for BREAST-MED TISSUE MARKER, manufactured by Breast-Med, Inc.. The device is a Class 2 General & Plastic Surgery device with product code NEU cleared through the Traditional 510(k) pathway after a 493-day FDA review.

K133697 · Breast-Med, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2015
Decision
493d
Days
Class 2
Risk

K133697 is an FDA 510(k) clearance for the BREAST-MED TISSUE MARKER. Classified as Marker, Radiographic, Implantable (product code NEU), Class II - Special Controls.

Submitted by Breast-Med, Inc. (Golden Valley, US). The FDA issued a Cleared decision on April 10, 2015 after a review of 493 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4300 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Breast-Med, Inc. devices

FDA 510(k) Submission Details - K133697

510(k) Number K133697 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2013
Decision Date April 10, 2015
Days to Decision 493 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
378d slower than avg
Panel avg: 115d · This submission: 493d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NEU Device Classification - Class 2, Special Controls

Product Code NEU Marker, Radiographic, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NEU Marker, Radiographic, Implantable

All 65
Devices cleared under the same product code (NEU) and FDA review panel - the closest regulatory comparables to K133697.
Magseed Magnetic Marker Systtem
K173587 · Endomagnetics Ltd., · Feb 2018
UltraCor Twirl Breast Tissue Marker
K152510 · Bard Peripheral Vascular, Inc. · May 2016
Beacon Fine Needle Fiducial System
K152586 · Covidien, LLC · Dec 2015
CAREFUSION GOLD TISSUE MARKER
K141722 · Care Fusion · Jan 2015
BNX Fine Needle Aspiration System
K142198 · Covidien, LLC · Oct 2014
ECHO TIP ULTRA FIDUCIAL NEEDLE
K141356 · Wilson-Cook Medical, Inc. · Jun 2014